Evidence map›Paper›PMID 29034109›Full record

ArticleEuropean journal of microbiology & immunology2017

Multidrug-Resistant

Eliane von Klitzing, Stefan Bereswill, Markus M Heimesaat

Open access · diamondAbstract read
In one paragraph

Article in European journal of microbiology & immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 55 citations in OpenAlex.

  1. mBio · 2025
    Article
  2. Article
  3. Article
  4. A Standardized Extract ofFrontiers in microbiology · 2022
    Article
  5. Article
  6. Article
  7. Full Transcriptomic Response ofFrontiers in microbiology · 2020
    Article
  8. Article
  9. Article
  10. Multidrug-ResistantFrontiers in immunology · 2019
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Eliane von KlitzingCharité - Universitätsmedizin Berlin, Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Microbiology and Hygiene, Berlin, Germany.
Stefan BereswillCharité - Universitätsmedizin Berlin, Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Microbiology and Hygiene, Berlin, Germany.
Markus M HeimesaatCharité - Universitätsmedizin Berlin, Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Microbiology and Hygiene, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEFreie Universität Berlin · DEHumboldt-Universität zu Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Health Organization has rated multidrug-resistant (MDR)

Indexed as

broad-spectrum antibiotic treatmentcolonization resistancecommensal Escherichia coliintestinal microbiotamulti-drug resistant Gram-negative bacteriapro-inflammatory immune responsesPseudomonas aeruginosasecondary abiotic (gnotobiotic) micesusceptibility to infectionsystemic sequelae of infection

Identifiers

PMID29034109
PMCPMC5632747
OpenAlexW2756407107

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.